001     276909
005     20240229162341.0
024 7 _ |a 10.1002/chem.202301260
|2 doi
024 7 _ |a pmid:37334753
|2 pmid
024 7 _ |a 0947-6539
|2 ISSN
024 7 _ |a 1521-3765
|2 ISSN
024 7 _ |a altmetric:152437789
|2 altmetric
037 _ _ |a DKFZ-2023-01202
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Johny, Jacob
|b 0
245 _ _ |a Surface Chemistry and Specific Surface Area rule the Efficiency of Gold Nanoparticle Sensitizers in Proton Therapy.
260 _ _ |a Weinheim
|c 2023
|b Wiley-VCH
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1694094827_5153
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Sep 6;29(50):e202301260
520 _ _ |a Gold nanoparticles (AuNPs) are known radiosensitizers in proton therapy (PT) applicable for the treatment of solid tumors, where they amplify production of reactive oxygen species (ROS). However, it is underexplored how this amplification is correlated with the AuNPs´ surface chemistry. To clarify this issue, we fabricated ligand-free AuNPs of different mean diameters by laser ablation in liquids (LAL) and laser fragmentation in liquids (LFL) and irradiated them with clinically relevant proton fields using water phantoms. ROS generation was monitored by the fluorescent dye 7-OH-coumarin. Our findings reveal an enhancement of ROS production driven by I) increased total particle surface area, II) utilization of ligand-free AuNPs avoiding sodium citrate as a radical quencher ligands, and III) a higher density of structural defects generated by LFL synthesis, indicated by surface charge density. Based on these findings it may be concluded that the surface chemistry is a major and underexplored contributor to ROS generation and sensitizing effects of AuNPs in PT. We further highlight the applicability of AuNPs in vitro in human medulloblastoma cells.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a clinical irradiation dose
|2 Other
650 _ 7 |a gold nanoparticle colloid
|2 Other
650 _ 7 |a hydroxyl radicals
|2 Other
650 _ 7 |a laser processing in liquids
|2 Other
650 _ 7 |a proton radiotherapy
|2 Other
700 1 _ |a van Halteren, Charlotte E R
|b 1
700 1 _ |a Cakir, Fatih-Can
|b 2
700 1 _ |a Zwiehoff, Sandra
|b 3
700 1 _ |a Behrends, Carina
|b 4
700 1 _ |a Bäumer, Christian
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Timmermann, Beate
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Rauschenbach, Laurèl
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Tippelt, Stephan
|b 8
700 1 _ |a Scheffler, Björn
|0 P:(DE-He78)157b41fc2b001b4eba0da40143f12f33
|b 9
|u dkfz
700 1 _ |a Schramm, Alexander
|b 10
700 1 _ |a Rehbock, Christoph
|b 11
700 1 _ |a Barcikowski, Stephan
|b 12
773 _ _ |a 10.1002/chem.202301260
|g p. e202301260
|0 PERI:(DE-600)1478547-X
|n 50
|p e202301260
|t Chemistry - a European journal
|v 29
|y 2023
|x 0947-6539
909 C O |p VDB
|o oai:inrepo02.dkfz.de:276909
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)157b41fc2b001b4eba0da40143f12f33
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2023
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2022-11-18
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1210
|2 StatID
|b Index Chemicus
|d 2022-11-18
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1200
|2 StatID
|b Chemical Reactions
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-18
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CHEM-EUR J : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-10-21
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-21
920 1 _ |0 I:(DE-He78)ED01-20160331
|k ED01
|l DKTK Koordinierungsstelle Essen/Düsseldorf
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)ED01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21